Amiflamine

CAS No. 77502-96-6

Amiflamine( 4-(dimethylamino)-alpha,2-dimethylphenethylamine )

Catalog No. M22235 CAS No. 77502-96-6

Amiflamine is an inhibitor of reversible MAO-A.The ex vivo approach was found to be valid for moclobemide in brain and liver and for cimoxatone in brain tissue; a slight underestimation of the MAO A inhibitory effect of the latter in the liver is likely.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
5MG 30 In Stock
10MG 48 In Stock
25MG 79 In Stock
50MG 116 In Stock
100MG 173 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Amiflamine
  • Note
    Research use only, not for human use.
  • Brief Description
    Amiflamine is an inhibitor of reversible MAO-A.The ex vivo approach was found to be valid for moclobemide in brain and liver and for cimoxatone in brain tissue; a slight underestimation of the MAO A inhibitory effect of the latter in the liver is likely.
  • Description
    Amiflamine is an inhibitor of reversible MAO-A.The ex vivo approach was found to be valid for moclobemide in brain and liver and for cimoxatone in brain tissue; a slight underestimation of the MAO A inhibitory effect of the latter in the liver is likely. Definite underestimation occurred with amiflamine in both tissues. Kinetic investigations using homogenates from pretreated rats showed amiflamine to be a competitive inhibitor; cimoxatone was competitive in the liver but showed a more complex pattern in the brain. Moclobemide was noncompetitive in both tissues, as has been shown previously for brofaremine. Moclobemide prevented the deamination of dopamine and serotonin released from their striatal stores by tetrabenazine nearly as efficiently as clorgyline at an otherwise equieffective dose; cimoxatone was somewhat less effective relative to the reference compound, as was brofaremine, which was however given at a more effective dose. Amiflamine was much less effective than clorgyline at protecting dopamine, but equieffective with respect to serotonin.Amiflamine was 3 times less potent within noradrenergic neurons than within serotonergic neurons. A brain to plasma ratio of about 20:1 was found for amiflamine and its metabolites. The plasma and the brain concentrations of the N-demethylated metabolite [FLA 788(+)] exceeded that of amiflamine after a single dose, whereas the N,N-demethylated [FLA 668(+)] was found in low concentrations. The effect on MAO-A correlated significantly with the plasma and the brain concentration of FLA 788(+).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    4-(dimethylamino)-alpha,2-dimethylphenethylamine
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    MAO
  • Recptor
    MAO-A
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    77502-96-6
  • Formula Weight
    192.3
  • Molecular Formula
    C12H20N2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (130.01 mM)
  • SMILES
    c1(c(ccc(c1)N(C)C)[C@@H](N)CC)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Waldmeier P C . On the reversibility of reversible MAO inhibitors[J]. Naunyn-Schmiedeberg's archives of pharmacology, 1985, 329(3):305-10.
molnova catalog
related products
  • MD 69276

    MD 69276 (Toloxatone) is a reversible monoamine oxidase A (MAOA) inhibitor.

  • Minaprine dihydrochl...

    Minaprine dihydrochloride is a reversible MAO-A?inhibitor; It weakly inhibit acetylcholinesterase. Minaprine dihydrochloride is an antidepressant for treatment of depression.

  • Osilodrostat

    Osilodrostat (LCI699) is an effective inhibitor of human 11β-hydroxylase (IC50: 2.5 nM) and aldosterone synthase (IC50: 0.7 nM).